清宣止咳颗粒治疗儿童感冒、支气管炎临床应用专家共识  

Expert consensus on clinical application of Qingxuan Zhike Granule in treating children's colds and bronchitis

作　　者：杜丽娜[1] 林丽丽[2] 韩姗姗[3] 杨燕[1] DU Lina;LIN Lili;HAN Shanshan;YANG Yan(National Center for Children's Health,Beijing Children's Hospital,Capital Medical University,Beijing 100045,China;Nanjing University of Chinese Medicine,Nanjing 210029,China;The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450003,China)

机构地区：[1]首都医科大学附属北京儿童医院,北京100045 [2]南京中医药大学,江苏南京210029 [3]河南中医药大学第一附属医院,河南郑州450003

出　　处：《药物评价研究》2024年第1期153-159,共7页Drug Evaluation Research

摘　　要：在系统回顾、梳理清宣止咳颗粒上市以来的临床及基础研究成果的基础上,采用国际临床医学专家共识研制方法,通过召开专家论证会及函审,结合现有循证证据制定本专家共识。共识对清宣止咳颗粒治疗儿童感冒、支气管炎的优势环节、给药方案与剂量疗程特点、安全性问题等进行了推荐或建议,并通过专家会议以及函审的方式,在全国范围内进行意见征求和同行评议,可为指导清宣止咳颗粒的临床合理用药提供参考。On the basis of systematic review and sorting out the clinical and basic research achievements of Qingxuan Zhike Granule since its listing,the international clinical medical expert consensus development method was adopted.This expert consensus was developed by holding expert review meetings and letter reviews,combined with existing evidence-based evidence.This consensus has recommended or suggested the advantages of Qingxuan Zhike Granule in treating children's colds and bronchitis,the characteristics of drug delivery scheme and dosage course,and safety issues,and has solicited opinions and peer reviews nationwide through expert meetings and letter reviews,which can provide reference for guiding the rational clini‐cal use of Qingxuan Zhike Granule.

关 键 词：清宣止咳颗粒 儿童感冒 儿童支气管炎 临床应用 合理用药 

分 类 号：R285.5[医药卫生—中药学]